We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1882:HKEXSANIGEN Analysis

Data as of 2026-06-13 - not real-time

¥1,512.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Toa Road Corp is trading at 1,512 JPY, just above its 20‑day SMA (1,511.2) but well below the 50‑day (1,590.9) and 200‑day (1,660.1) averages, indicating a short‑term bounce within a longer‑term bearish framework. The RSI sits at 43, suggesting neutral momentum, while the MACD histogram has turned positive, hinting at emerging bullish pressure. Valuation metrics are compelling: the stock’s P/E of 17.5 is less than half the industry average of 30.6, and the DCF‑derived fair value of ~2,777 JPY implies upside of over 80%. However, the dividend payout ratio of 156% raises concerns about dividend sustainability. Fundamentals show modest profitability (net margin 2.8%) and a slight revenue decline of 2.1%, but a strong cash position (13.9 B JPY) offsets a modest debt load (4.6 B JPY). Volatility is elevated at 20.7% over 30 days, yet beta is low (~0.13), indicating limited market‑wide risk.
Given the sizable valuation gap, low systematic risk, and improving technical signals, the stock presents a value‑oriented opportunity for investors with a longer horizon, while short‑term traders should monitor the 1,467 JPY support and 1,567 JPY resistance levels for entry cues.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near support at 1,468 JPY
  • Positive MACD histogram indicating early bullish momentum
  • High dividend yield but unsustainable payout ratio

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Valuation upside of >80% versus DCF fair value
  • Low beta and strong cash position reducing downside risk
  • Technical momentum building toward 1,567 JPY resistance

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap relative to industry peers
  • Stable earnings base with solid free cash flow generation
  • Low systematic risk and favorable dividend yield if payout improves

Key Metrics & Analysis

Financial Health

Revenue Growth-2.10%
Profit Margin2.82%
P/E Ratio17.5
ROE6.31%
ROA4.04%
Debt/Equity8.41
P/B Ratio1.3
Op. Cash Flow¥12.2B
Free Cash Flow¥9.0B
Industry P/E30.6

Technical Analysis

TrendBearish
RSI43.3
Support¥1,468.00
Resistance¥1,567.00
MA 20¥1,511.20
MA 50¥1,590.90
MA 200¥1,660.06
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value¥2,776.89
GradeUndervalued
TypeValue
Dividend Yield5.95%

Risk Assessment

Beta0.13
Volatility20.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.